SlideShare une entreprise Scribd logo
Hemodynamic Disorders
(Edema, hemorrhage, shock and Thromboembolic Disease)
Dr. Kagnew
4/9/2024 1
Outlines
• Edema,
• Hemorrhage,
• shock,
• Thromboembolism.
4/9/2024 2
Objectives
• At the end of the class students are expected to
know about;
Know mechanism of edema,
Causes of hemorrhage,
Understand different types of shock,
Know about Virchow's triads of thrombosis.
4/9/2024 3
Introduction
• The health of cells and organs critically depends on
an unbroken circulation to deliver oxygen and
nutrients and to remove wastes.
• However, the well-being of tissues also requires
normal fluid balance
4/9/2024 4
Con’t…
• Changes in vascular volume, pressure, or protein
content, or alterations in endothelial function, all
affect the net movement of water across the vascular
wall.
• Such water extravasation into the interstitial spaces
is called edema.
4/9/2024 5
Con’t…
• Clotting at inappropriate sites (thrombosis) or
migration of clots (embolism) obstructs blood flow
to tissues and leads to cell death (infarction).
• Conversely, inability to clot after vascular injury
results in hemorrhage;
• Local bleeding can compromise regional tissue
perfusion, while more extensive hemorrhage can
result in hypotension (shock) and death.
4/9/2024 6
1. Edema
• Approximately 60% of lean body weight is water;
two thirds of this water is intracellular, and
the remainder is found in the extracellular space,
mostly as interstitial fluid (only about 5% of total
body water is in blood plasma).
• The term edema signifies increased fluid in the
interstitial tissue spaces.
• Anasarca is a severe and generalized edema with
profound subcutaneous tissue swelling.
4/9/2024 7
Con’t…
• In general, the opposing effects of vascular
hydrostatic pressure and plasma colloid osmotic
pressure are the major factors that govern
movement of fluid between vascular and interstitial
spaces.
• Either increased capillary pressure or diminished
colloid osmotic pressure can result in increased
interstitial fluid === Edema.
4/9/2024 8
Con’t…
• Edema is most easily recognized grossly;
• Although any organ or tissue in the body may be
involved, edema is most commonly encountered in
subcutaneous tissues, the lungs, and the brain.
4/9/2024 9
Con’t…
Subcutaneous edema
• may have different distributions depending on the
cause.
• The edema distribution is typically influenced by
gravity and is termed dependent edema
• Edema of the dependent parts of the body (e.g., the
legs when standing, the sacrum when recumbent)
is a prominent feature of congestive heart failure,
4/9/2024 10
Con’t…
• Edema as a result of renal dysfunction or nephrotic
syndrome is generally more severe than cardiac
edema and affects all parts of the body equally.
 It may, however, initially manifest itself in tissues
with a loose connective tissue matrix, such as the
eyelids;
 Periorbital edema is a characteristic finding in
severe renal disease.
• Pitting edema= depression when pressure applied
4/9/2024 11
Causes of Edema
4/9/2024 12
2. Hemorrhage
• Hemorrhage, defined as the extravasation of blood
from vessels, is most often the result of damage to
blood vessels or defective clot formation.
• Hemorrhage may be manifested in a variety of
patterns, depending on the size, extent, and location
of bleeding.
• Hemorrhage may be external or may be enclosed
within a tissue;
• Accumulation of blood within tissue is referred to as
a hematoma.
4/9/2024 13
Con’t…
• 1- to 2-mm hemorrhages into skin, mucous membranes
are denoted as petechiae
• Slightly larger (≥3 mm) hemorrhages are called
purpura.
• Larger (>1 to 2 cm) subcutaneous hematomas are called
ecchymoses
• Large accumulations of blood in the body cavities are
called;
Hemothorax (in pleural cavity ),
Hemopericardium (in pericardial cavity ),
Hemoperitoneum ( in peritoneal cavity), or
hemarthrosis (in joints).
4/9/2024 14
Con’t…
• The clinical significance of hemorrhage depends on
the volume and rate of bleeding.
• Rapid loss of up to 20% of the blood volume or slow
losses of even larger amounts may have little impact
in healthy adults;
• Greater losses, however, may result in hemorrhagic
(hypovolemic) shock.
• The site of hemorrhage is also important;
 Bleeding that would be trivial in the subcutaneous
tissues may cause death if located in the brain.
4/9/2024 15
Con’t…
• Finally, chronic or recurrent external blood loss
(e.g., due to peptic ulcer or menstrual
bleeding)frequently cause iron deficiency anemia as
a consequence of a loss of iron in hemoglobin.
• By contrast, iron is efficiently recycled from
phagocytosed red cells, so internal bleeding (e.g., a
hematoma) does not lead to iron deficiency.
4/9/2024 16
3. Shock
• Shock is a state in which diminished cardiac output
or reduced effective circulating blood volume
impairs tissue perfusion and leads to cellular
hypoxia.
17
4/9/2024
Major types of shock
4/9/2024 18
Classification of shock
A. Hypovolemic shock
B. Cardiogenic shock
C. Distributive shock
19
4/9/2024
A. Hypovolemic shock
• Definition: This is shock caused by reduced blood
volume.
•Causes of hypovolumic shock include:
a)Haemorrhage
b)Diarrhoea & vomiting
c)Burns
d)Trauma
20
4/9/2024
• Hypovolumic shock is the most common type of
shock in clinical medicine .
•A normal healthy adult can lose 550ml (10% of blood
volume) without significant symptoms.
•But loss of 25% or more of the blood volume
(N=1250ml) results in significant hypovolemia.
21
4/9/2024
B. Cardiogenic shock
• Definition: This is shock that results from severe
depression of cardiac performance.
• It primarily results from pump failure [myocardial
failure].
• Example of causes of cardiogenic shock :
–Acute Myocardial Infarction (MI)
–Cardiac Myopathy
22
4/9/2024
C. Distributive shock
• Definition: Distributive shock refers to a group of
shock subtypes caused by peripheral vasodilatation
despite normal or high cardiac output.
• Causes of distributive shock
1.Septic shock – the commonest among the group
2.Neurogenic shock
3.Anaphylactic shock
4.Endocrine shock
23
4/9/2024
Septic shock
• Caused by the host response to bacterial, viral or
fungal infections.
• Systemic inflammatory condition characterized by
Endothelial cell activation,
Tissue edema,
 Disseminated intravascular coagulation, and
Metabolic derangements
24
4/9/2024
Major pathogenic pathways in septic shock
25
4/9/2024
Stages of Shock
• Non progressive stage- reflex compensatory
mechanisms are activated and perfusion of vital
organs is maintained
• Progressive stage : tissue hypoperfusion and onset
of worsening circulatory and metabolic imbalances,
including lactic acidosis
• Irreversible stage: cellular and tissue injury severe
,survival is not possible
26
4/9/2024
4. Hemostasis and Thrombosis
• Normal hemostasis comprises a series of
regulated processes that culminate in the
formation of a blood clot that limits bleeding
from an injured vessel.
• The pathologic counterpart of hemostasis is
thrombosis, the formation of blood clot
(thrombus) within non-traumatized, intact
vessels.
4/9/2024 27
Normal hemostasis
4/9/2024 28
4/9/2024 29
Con’t..
• The pathologic opposite to hemostasis is thrombosis;
• Thrombosis can be considered as an inappropriate
activation of normal hemostatic processes,
such as the formation of a blood clot (thrombus) in
uninjured vasculature or thrombotic occlusion of a
vessel after relatively minor injury.
• Both hemostasis and thrombosis are regulated by three
general components—
the vascular wall,
platelets, and
the coagulation cascade.
4/9/2024 30
Thrombosis
• Three primary influences predispose to thrombus
formation, the so-called Virchow’s triad:
(1) Endothelial injury;
(2) Stasis or turbulence of blood flow; and
(3) Blood hypercoagulability
4/9/2024 31
4/9/2024 32
1. Endothelial Injury
• It has the dominant influence; endothelial injury by
itself can lead to thrombosis.
• It is particularly important for thrombus formation
occurring in the heart or in the arterial circulation,
• Thus, thrombus formation within the cardiac
chambers (e.g., following endocardial injury due to
myocardial infarction), or
• at sites of traumatic or inflammatory vascular injury
(vasculitis) is largely due to endothelial injury.
4/9/2024 33
2.Alterations in Normal Blood Flow/Stasis
• Turbulence contributes to arterial and cardiac
thrombosis by causing;
o endothelial injury or dysfunction
o as well as by forming countercurrents and local
pockets of stasis;
stasis is a major factor in the development of venous
thrombi
4/9/2024 34
• Normal blood flow is laminar such that the platelets
flow centrally in the vessel lumen, separated from the
endothelium by a slower-moving clear zone of
plasma.
• Stasis and turbulence therefore
(1) disrupt laminar flow and bring platelets into contact
with the endothelium;
(2) prevent dilution of activated clotting factors by fresh
flowing blood;
(3) retard the inflow of clotting factor inhibitors and
permit the build-up of thrombi; and
(4) promote endothelial cell activation, predisposing to
local thrombosis, leukocyte adhesion
4/9/2024 35
3. Hypercoagulability
• Hypercoagulability contributes less frequently to
thrombotic states.
• It is defined as any alteration of the coagulation
pathways that predisposes to thrombosis.
• The causes of hypercoagulability may be primary
(genetic) and secondary (acquired) disorders
- Example: pregnancy , HIV/AIDS, Cancer …
4/9/2024 36
• Thrombi may develop anywhere in the
cardiovascular system:
within the cardiac chambers;
on valve cusps; or
in arteries, veins, or capillaries.
• They are of variable size and shape, depending on
the site of origin and the circumstances leading to
their development.
4/9/2024 37
• Arterial or cardiac thrombi usually begin at a site of
endothelial injury (e.g., atherosclerotic plaque) or
turbulence (vessel bifurcation);
• venous thrombi characteristically occur in sites of
stasis.
• An area of attachment to the underlying vessel or
heart wall, frequently firmest at the point of origin,
is characteristic of all thromboses.
• The propagating tail may not be well attached and,
particularly in veins, is prone to fragmentation,
creating an embolus.
4/9/2024 38
Arterial thrombi :
• are usually occlusive;
• the most common sites, in descending order,
Coronary A,
Cerebral A, and
 femoral arteries.
4/9/2024 39
Fate of the Thrombus
• Thrombi undergo some combination of the
following four events in days to weeks
1. Propagation. The thrombus may accumulate more
platelets and fibrin (propagate), eventually leading
to vessel obstruction.
2. Embolization. Thrombi may dislodge and travel to
other sites in the vasculature (eg to lung ).
4/9/2024 40
3. Dissolution. Thrombi may be removed by
fibrinolytic activity
4. Organization and recanalization. Thrombi may
induce inflammation and fibrosis (organization) and
may eventually become recanalized; that is,
may reestablish vascular flow, or
may be incorporated into a thickened vascular wall
4/9/2024 41
Outcomes of venous thrombosis
4/9/2024 42
REFERENCE
43
4/9/2024
Thank you!!!
Question?
4/9/2024 44

Contenu connexe

Similaire à 6. Hemodynamic Disorders, Thromboembolic Disease.pptx

Embolism, Infarction and Shock ppt-1 slides.pptx
Embolism, Infarction and Shock ppt-1 slides.pptxEmbolism, Infarction and Shock ppt-1 slides.pptx
Embolism, Infarction and Shock ppt-1 slides.pptx
SahalIsmailOmar
 
HYPEREMIA.pptx
HYPEREMIA.pptxHYPEREMIA.pptx
HYPEREMIA.pptx
Muhammad Zafar
 
HYPEREMIA.pptx
HYPEREMIA.pptxHYPEREMIA.pptx
HYPEREMIA.pptx
Muhammad Zafar
 
Hemodynamic Disorders.pptx
Hemodynamic Disorders.pptxHemodynamic Disorders.pptx
Hemodynamic Disorders.pptx
Abazar Amar
 
Embolism & Hemorrhage.pptx
Embolism & Hemorrhage.pptxEmbolism & Hemorrhage.pptx
Embolism & Hemorrhage.pptx
MKashif39
 
hemodynamics disorder pathophysiology .pptx
hemodynamics disorder pathophysiology .pptxhemodynamics disorder pathophysiology .pptx
hemodynamics disorder pathophysiology .pptx
AkilanN5
 
6 infarction
6 infarction6 infarction
6 infarction
Prasad CSBR
 
5) Thromboembolism 2021 .ppt presentation
5) Thromboembolism 2021 .ppt presentation5) Thromboembolism 2021 .ppt presentation
5) Thromboembolism 2021 .ppt presentation
PujaSingh347626
 
4.Circulation.disorders.pdf
4.Circulation.disorders.pdf4.Circulation.disorders.pdf
4.Circulation.disorders.pdf
Prakash554699
 
EMBOLISM -1
EMBOLISM -1EMBOLISM -1
EMBOLISM -1
Dr. Roopam Jain
 
Circulatory disorders
Circulatory disordersCirculatory disorders
Circulatory disorders
RASHA
 
Infarction Path-201.pptx
Infarction Path-201.pptxInfarction Path-201.pptx
Infarction Path-201.pptx
NOKHAIZHAMMAD2021BSM
 
Hemodynamic Disorders
Hemodynamic DisordersHemodynamic Disorders
Hemodynamic Disorders
Hadi Munib
 
Class IV NR.pptx
Class IV NR.pptxClass IV NR.pptx
Class IV NR.pptx
elahinge1
 
Hemostasis; intravascular coagulation and anticoagulation
Hemostasis; intravascular coagulation and anticoagulationHemostasis; intravascular coagulation and anticoagulation
Hemostasis; intravascular coagulation and anticoagulation
sanaakram65
 
Pathology of hemodynamic disorders part 2 nov 2017 Dr. Sufia Husain
Pathology of hemodynamic disorders part 2 nov 2017 Dr. Sufia HusainPathology of hemodynamic disorders part 2 nov 2017 Dr. Sufia Husain
Pathology of hemodynamic disorders part 2 nov 2017 Dr. Sufia Husain
Sufia Husain
 
Myocardial infarction
Myocardial infarctionMyocardial infarction
Myocardial infarction
utsav parmar
 
INFARCTION
INFARCTION INFARCTION
INFARCTION
Ahmed Alsaady
 
Ischemia and Infarction.pdf
Ischemia and Infarction.pdfIschemia and Infarction.pdf
Ischemia and Infarction.pdf
UVAS
 
vascular changes in inflamation
vascular changes in inflamationvascular changes in inflamation
vascular changes in inflamation
ankur16491
 

Similaire à 6. Hemodynamic Disorders, Thromboembolic Disease.pptx (20)

Embolism, Infarction and Shock ppt-1 slides.pptx
Embolism, Infarction and Shock ppt-1 slides.pptxEmbolism, Infarction and Shock ppt-1 slides.pptx
Embolism, Infarction and Shock ppt-1 slides.pptx
 
HYPEREMIA.pptx
HYPEREMIA.pptxHYPEREMIA.pptx
HYPEREMIA.pptx
 
HYPEREMIA.pptx
HYPEREMIA.pptxHYPEREMIA.pptx
HYPEREMIA.pptx
 
Hemodynamic Disorders.pptx
Hemodynamic Disorders.pptxHemodynamic Disorders.pptx
Hemodynamic Disorders.pptx
 
Embolism & Hemorrhage.pptx
Embolism & Hemorrhage.pptxEmbolism & Hemorrhage.pptx
Embolism & Hemorrhage.pptx
 
hemodynamics disorder pathophysiology .pptx
hemodynamics disorder pathophysiology .pptxhemodynamics disorder pathophysiology .pptx
hemodynamics disorder pathophysiology .pptx
 
6 infarction
6 infarction6 infarction
6 infarction
 
5) Thromboembolism 2021 .ppt presentation
5) Thromboembolism 2021 .ppt presentation5) Thromboembolism 2021 .ppt presentation
5) Thromboembolism 2021 .ppt presentation
 
4.Circulation.disorders.pdf
4.Circulation.disorders.pdf4.Circulation.disorders.pdf
4.Circulation.disorders.pdf
 
EMBOLISM -1
EMBOLISM -1EMBOLISM -1
EMBOLISM -1
 
Circulatory disorders
Circulatory disordersCirculatory disorders
Circulatory disorders
 
Infarction Path-201.pptx
Infarction Path-201.pptxInfarction Path-201.pptx
Infarction Path-201.pptx
 
Hemodynamic Disorders
Hemodynamic DisordersHemodynamic Disorders
Hemodynamic Disorders
 
Class IV NR.pptx
Class IV NR.pptxClass IV NR.pptx
Class IV NR.pptx
 
Hemostasis; intravascular coagulation and anticoagulation
Hemostasis; intravascular coagulation and anticoagulationHemostasis; intravascular coagulation and anticoagulation
Hemostasis; intravascular coagulation and anticoagulation
 
Pathology of hemodynamic disorders part 2 nov 2017 Dr. Sufia Husain
Pathology of hemodynamic disorders part 2 nov 2017 Dr. Sufia HusainPathology of hemodynamic disorders part 2 nov 2017 Dr. Sufia Husain
Pathology of hemodynamic disorders part 2 nov 2017 Dr. Sufia Husain
 
Myocardial infarction
Myocardial infarctionMyocardial infarction
Myocardial infarction
 
INFARCTION
INFARCTION INFARCTION
INFARCTION
 
Ischemia and Infarction.pdf
Ischemia and Infarction.pdfIschemia and Infarction.pdf
Ischemia and Infarction.pdf
 
vascular changes in inflamation
vascular changes in inflamationvascular changes in inflamation
vascular changes in inflamation
 

Plus de ErmiyasBeletew

6 Occupational health and safety 2016 PHO II.pdf
6 Occupational health and safety 2016 PHO II.pdf6 Occupational health and safety 2016 PHO II.pdf
6 Occupational health and safety 2016 PHO II.pdf
ErmiyasBeletew
 
2024 Chapter 5 Adexhhhhhhhhhhhhhhhhhhhhhhh.pptx
2024 Chapter 5 Adexhhhhhhhhhhhhhhhhhhhhhhh.pptx2024 Chapter 5 Adexhhhhhhhhhhhhhhhhhhhhhhh.pptx
2024 Chapter 5 Adexhhhhhhhhhhhhhhhhhhhhhhh.pptx
ErmiyasBeletew
 
3 ENVIRO GROUP 2 correct ed.ppt
3 ENVIRO GROUP 2  correct                                  ed.ppt3 ENVIRO GROUP 2  correct                                  ed.ppt
3 ENVIRO GROUP 2 correct ed.ppt
ErmiyasBeletew
 
2024_Chapter_4_Edited_Cellular_Metabolism_and_Metabolic_Disorders (4).pptx
2024_Chapter_4_Edited_Cellular_Metabolism_and_Metabolic_Disorders (4).pptx2024_Chapter_4_Edited_Cellular_Metabolism_and_Metabolic_Disorders (4).pptx
2024_Chapter_4_Edited_Cellular_Metabolism_and_Metabolic_Disorders (4).pptx
ErmiyasBeletew
 
4 Blood cology Public Health -rtttttttttttt pdf.pdf
4 Blood cology Public Health -rtttttttttttt pdf.pdf4 Blood cology Public Health -rtttttttttttt pdf.pdf
4 Blood cology Public Health -rtttttttttttt pdf.pdf
ErmiyasBeletew
 
Hema Chapter 24_Hemostasisnnnnnnnnnnnnnnnn (2).ppt
Hema Chapter 24_Hemostasisnnnnnnnnnnnnnnnn (2).pptHema Chapter 24_Hemostasisnnnnnnnnnnnnnnnn (2).ppt
Hema Chapter 24_Hemostasisnnnnnnnnnnnnnnnn (2).ppt
ErmiyasBeletew
 
Antimalaria.gggggggggggggggggggggggggggggggggggggggggpptx
Antimalaria.gggggggggggggggggggggggggggggggggggggggggpptxAntimalaria.gggggggggggggggggggggggggggggggggggggggggpptx
Antimalaria.gggggggggggggggggggggggggggggggggggggggggpptx
ErmiyasBeletew
 
Atidepressant,,,,readiHGGGGGGGGGGGGGGGGGGGGGGGGGGng.ppt
Atidepressant,,,,readiHGGGGGGGGGGGGGGGGGGGGGGGGGGng.pptAtidepressant,,,,readiHGGGGGGGGGGGGGGGGGGGGGGGGGGng.ppt
Atidepressant,,,,readiHGGGGGGGGGGGGGGGGGGGGGGGGGGng.ppt
ErmiyasBeletew
 
Unit 3.nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnpptx
Unit 3.nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnpptxUnit 3.nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnpptx
Unit 3.nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnpptx
ErmiyasBeletew
 
Chapter III.jjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjpptx
Chapter III.jjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjpptxChapter III.jjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjpptx
Chapter III.jjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjpptx
ErmiyasBeletew
 
p.pyramid ppt group -klllllllllllllllllll4.pptx
p.pyramid ppt group -klllllllllllllllllll4.pptxp.pyramid ppt group -klllllllllllllllllll4.pptx
p.pyramid ppt group -klllllllllllllllllll4.pptx
ErmiyasBeletew
 
GENERAL ANESTHETICShhhhhhhhhhhhhhhhhhhhh.ppt
GENERAL ANESTHETICShhhhhhhhhhhhhhhhhhhhh.pptGENERAL ANESTHETICShhhhhhhhhhhhhhhhhhhhh.ppt
GENERAL ANESTHETICShhhhhhhhhhhhhhhhhhhhh.ppt
ErmiyasBeletew
 
Chapter 5b- CVSvvvvvvvvvvvvvvvvvvvvvv.pptx
Chapter 5b- CVSvvvvvvvvvvvvvvvvvvvvvv.pptxChapter 5b- CVSvvvvvvvvvvvvvvvvvvvvvv.pptx
Chapter 5b- CVSvvvvvvvvvvvvvvvvvvvvvv.pptx
ErmiyasBeletew
 
1. AKI.pptxbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbb
1. AKI.pptxbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbb1. AKI.pptxbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbb
1. AKI.pptxbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbb
ErmiyasBeletew
 
1 Presentation7[1] correctefgggggfffhhhhhhd.ppt
1 Presentation7[1] correctefgggggfffhhhhhhd.ppt1 Presentation7[1] correctefgggggfffhhhhhhd.ppt
1 Presentation7[1] correctefgggggfffhhhhhhd.ppt
ErmiyasBeletew
 
2 environmental health1 corr ected.ppt
2 environmental health1 corr                         ected.ppt2 environmental health1 corr                         ected.ppt
2 environmental health1 corr ected.ppt
ErmiyasBeletew
 
4 Group 1 correctedhhhhhhhhhhhhhhhhhhhhhhhhh.ppt
4 Group 1 correctedhhhhhhhhhhhhhhhhhhhhhhhhh.ppt4 Group 1 correctedhhhhhhhhhhhhhhhhhhhhhhhhh.ppt
4 Group 1 correctedhhhhhhhhhhhhhhhhhhhhhhhhh.ppt
ErmiyasBeletew
 

Plus de ErmiyasBeletew (17)

6 Occupational health and safety 2016 PHO II.pdf
6 Occupational health and safety 2016 PHO II.pdf6 Occupational health and safety 2016 PHO II.pdf
6 Occupational health and safety 2016 PHO II.pdf
 
2024 Chapter 5 Adexhhhhhhhhhhhhhhhhhhhhhhh.pptx
2024 Chapter 5 Adexhhhhhhhhhhhhhhhhhhhhhhh.pptx2024 Chapter 5 Adexhhhhhhhhhhhhhhhhhhhhhhh.pptx
2024 Chapter 5 Adexhhhhhhhhhhhhhhhhhhhhhhh.pptx
 
3 ENVIRO GROUP 2 correct ed.ppt
3 ENVIRO GROUP 2  correct                                  ed.ppt3 ENVIRO GROUP 2  correct                                  ed.ppt
3 ENVIRO GROUP 2 correct ed.ppt
 
2024_Chapter_4_Edited_Cellular_Metabolism_and_Metabolic_Disorders (4).pptx
2024_Chapter_4_Edited_Cellular_Metabolism_and_Metabolic_Disorders (4).pptx2024_Chapter_4_Edited_Cellular_Metabolism_and_Metabolic_Disorders (4).pptx
2024_Chapter_4_Edited_Cellular_Metabolism_and_Metabolic_Disorders (4).pptx
 
4 Blood cology Public Health -rtttttttttttt pdf.pdf
4 Blood cology Public Health -rtttttttttttt pdf.pdf4 Blood cology Public Health -rtttttttttttt pdf.pdf
4 Blood cology Public Health -rtttttttttttt pdf.pdf
 
Hema Chapter 24_Hemostasisnnnnnnnnnnnnnnnn (2).ppt
Hema Chapter 24_Hemostasisnnnnnnnnnnnnnnnn (2).pptHema Chapter 24_Hemostasisnnnnnnnnnnnnnnnn (2).ppt
Hema Chapter 24_Hemostasisnnnnnnnnnnnnnnnn (2).ppt
 
Antimalaria.gggggggggggggggggggggggggggggggggggggggggpptx
Antimalaria.gggggggggggggggggggggggggggggggggggggggggpptxAntimalaria.gggggggggggggggggggggggggggggggggggggggggpptx
Antimalaria.gggggggggggggggggggggggggggggggggggggggggpptx
 
Atidepressant,,,,readiHGGGGGGGGGGGGGGGGGGGGGGGGGGng.ppt
Atidepressant,,,,readiHGGGGGGGGGGGGGGGGGGGGGGGGGGng.pptAtidepressant,,,,readiHGGGGGGGGGGGGGGGGGGGGGGGGGGng.ppt
Atidepressant,,,,readiHGGGGGGGGGGGGGGGGGGGGGGGGGGng.ppt
 
Unit 3.nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnpptx
Unit 3.nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnpptxUnit 3.nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnpptx
Unit 3.nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnpptx
 
Chapter III.jjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjpptx
Chapter III.jjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjpptxChapter III.jjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjpptx
Chapter III.jjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjpptx
 
p.pyramid ppt group -klllllllllllllllllll4.pptx
p.pyramid ppt group -klllllllllllllllllll4.pptxp.pyramid ppt group -klllllllllllllllllll4.pptx
p.pyramid ppt group -klllllllllllllllllll4.pptx
 
GENERAL ANESTHETICShhhhhhhhhhhhhhhhhhhhh.ppt
GENERAL ANESTHETICShhhhhhhhhhhhhhhhhhhhh.pptGENERAL ANESTHETICShhhhhhhhhhhhhhhhhhhhh.ppt
GENERAL ANESTHETICShhhhhhhhhhhhhhhhhhhhh.ppt
 
Chapter 5b- CVSvvvvvvvvvvvvvvvvvvvvvv.pptx
Chapter 5b- CVSvvvvvvvvvvvvvvvvvvvvvv.pptxChapter 5b- CVSvvvvvvvvvvvvvvvvvvvvvv.pptx
Chapter 5b- CVSvvvvvvvvvvvvvvvvvvvvvv.pptx
 
1. AKI.pptxbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbb
1. AKI.pptxbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbb1. AKI.pptxbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbb
1. AKI.pptxbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbb
 
1 Presentation7[1] correctefgggggfffhhhhhhd.ppt
1 Presentation7[1] correctefgggggfffhhhhhhd.ppt1 Presentation7[1] correctefgggggfffhhhhhhd.ppt
1 Presentation7[1] correctefgggggfffhhhhhhd.ppt
 
2 environmental health1 corr ected.ppt
2 environmental health1 corr                         ected.ppt2 environmental health1 corr                         ected.ppt
2 environmental health1 corr ected.ppt
 
4 Group 1 correctedhhhhhhhhhhhhhhhhhhhhhhhhh.ppt
4 Group 1 correctedhhhhhhhhhhhhhhhhhhhhhhhhh.ppt4 Group 1 correctedhhhhhhhhhhhhhhhhhhhhhhhhh.ppt
4 Group 1 correctedhhhhhhhhhhhhhhhhhhhhhhhhh.ppt
 

Dernier

Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treatHistopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
DIVYANSHU740006
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 

Dernier (20)

Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treatHistopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 

6. Hemodynamic Disorders, Thromboembolic Disease.pptx

  • 1. Hemodynamic Disorders (Edema, hemorrhage, shock and Thromboembolic Disease) Dr. Kagnew 4/9/2024 1
  • 2. Outlines • Edema, • Hemorrhage, • shock, • Thromboembolism. 4/9/2024 2
  • 3. Objectives • At the end of the class students are expected to know about; Know mechanism of edema, Causes of hemorrhage, Understand different types of shock, Know about Virchow's triads of thrombosis. 4/9/2024 3
  • 4. Introduction • The health of cells and organs critically depends on an unbroken circulation to deliver oxygen and nutrients and to remove wastes. • However, the well-being of tissues also requires normal fluid balance 4/9/2024 4
  • 5. Con’t… • Changes in vascular volume, pressure, or protein content, or alterations in endothelial function, all affect the net movement of water across the vascular wall. • Such water extravasation into the interstitial spaces is called edema. 4/9/2024 5
  • 6. Con’t… • Clotting at inappropriate sites (thrombosis) or migration of clots (embolism) obstructs blood flow to tissues and leads to cell death (infarction). • Conversely, inability to clot after vascular injury results in hemorrhage; • Local bleeding can compromise regional tissue perfusion, while more extensive hemorrhage can result in hypotension (shock) and death. 4/9/2024 6
  • 7. 1. Edema • Approximately 60% of lean body weight is water; two thirds of this water is intracellular, and the remainder is found in the extracellular space, mostly as interstitial fluid (only about 5% of total body water is in blood plasma). • The term edema signifies increased fluid in the interstitial tissue spaces. • Anasarca is a severe and generalized edema with profound subcutaneous tissue swelling. 4/9/2024 7
  • 8. Con’t… • In general, the opposing effects of vascular hydrostatic pressure and plasma colloid osmotic pressure are the major factors that govern movement of fluid between vascular and interstitial spaces. • Either increased capillary pressure or diminished colloid osmotic pressure can result in increased interstitial fluid === Edema. 4/9/2024 8
  • 9. Con’t… • Edema is most easily recognized grossly; • Although any organ or tissue in the body may be involved, edema is most commonly encountered in subcutaneous tissues, the lungs, and the brain. 4/9/2024 9
  • 10. Con’t… Subcutaneous edema • may have different distributions depending on the cause. • The edema distribution is typically influenced by gravity and is termed dependent edema • Edema of the dependent parts of the body (e.g., the legs when standing, the sacrum when recumbent) is a prominent feature of congestive heart failure, 4/9/2024 10
  • 11. Con’t… • Edema as a result of renal dysfunction or nephrotic syndrome is generally more severe than cardiac edema and affects all parts of the body equally.  It may, however, initially manifest itself in tissues with a loose connective tissue matrix, such as the eyelids;  Periorbital edema is a characteristic finding in severe renal disease. • Pitting edema= depression when pressure applied 4/9/2024 11
  • 13. 2. Hemorrhage • Hemorrhage, defined as the extravasation of blood from vessels, is most often the result of damage to blood vessels or defective clot formation. • Hemorrhage may be manifested in a variety of patterns, depending on the size, extent, and location of bleeding. • Hemorrhage may be external or may be enclosed within a tissue; • Accumulation of blood within tissue is referred to as a hematoma. 4/9/2024 13
  • 14. Con’t… • 1- to 2-mm hemorrhages into skin, mucous membranes are denoted as petechiae • Slightly larger (≥3 mm) hemorrhages are called purpura. • Larger (>1 to 2 cm) subcutaneous hematomas are called ecchymoses • Large accumulations of blood in the body cavities are called; Hemothorax (in pleural cavity ), Hemopericardium (in pericardial cavity ), Hemoperitoneum ( in peritoneal cavity), or hemarthrosis (in joints). 4/9/2024 14
  • 15. Con’t… • The clinical significance of hemorrhage depends on the volume and rate of bleeding. • Rapid loss of up to 20% of the blood volume or slow losses of even larger amounts may have little impact in healthy adults; • Greater losses, however, may result in hemorrhagic (hypovolemic) shock. • The site of hemorrhage is also important;  Bleeding that would be trivial in the subcutaneous tissues may cause death if located in the brain. 4/9/2024 15
  • 16. Con’t… • Finally, chronic or recurrent external blood loss (e.g., due to peptic ulcer or menstrual bleeding)frequently cause iron deficiency anemia as a consequence of a loss of iron in hemoglobin. • By contrast, iron is efficiently recycled from phagocytosed red cells, so internal bleeding (e.g., a hematoma) does not lead to iron deficiency. 4/9/2024 16
  • 17. 3. Shock • Shock is a state in which diminished cardiac output or reduced effective circulating blood volume impairs tissue perfusion and leads to cellular hypoxia. 17 4/9/2024
  • 18. Major types of shock 4/9/2024 18
  • 19. Classification of shock A. Hypovolemic shock B. Cardiogenic shock C. Distributive shock 19 4/9/2024
  • 20. A. Hypovolemic shock • Definition: This is shock caused by reduced blood volume. •Causes of hypovolumic shock include: a)Haemorrhage b)Diarrhoea & vomiting c)Burns d)Trauma 20 4/9/2024
  • 21. • Hypovolumic shock is the most common type of shock in clinical medicine . •A normal healthy adult can lose 550ml (10% of blood volume) without significant symptoms. •But loss of 25% or more of the blood volume (N=1250ml) results in significant hypovolemia. 21 4/9/2024
  • 22. B. Cardiogenic shock • Definition: This is shock that results from severe depression of cardiac performance. • It primarily results from pump failure [myocardial failure]. • Example of causes of cardiogenic shock : –Acute Myocardial Infarction (MI) –Cardiac Myopathy 22 4/9/2024
  • 23. C. Distributive shock • Definition: Distributive shock refers to a group of shock subtypes caused by peripheral vasodilatation despite normal or high cardiac output. • Causes of distributive shock 1.Septic shock – the commonest among the group 2.Neurogenic shock 3.Anaphylactic shock 4.Endocrine shock 23 4/9/2024
  • 24. Septic shock • Caused by the host response to bacterial, viral or fungal infections. • Systemic inflammatory condition characterized by Endothelial cell activation, Tissue edema,  Disseminated intravascular coagulation, and Metabolic derangements 24 4/9/2024
  • 25. Major pathogenic pathways in septic shock 25 4/9/2024
  • 26. Stages of Shock • Non progressive stage- reflex compensatory mechanisms are activated and perfusion of vital organs is maintained • Progressive stage : tissue hypoperfusion and onset of worsening circulatory and metabolic imbalances, including lactic acidosis • Irreversible stage: cellular and tissue injury severe ,survival is not possible 26 4/9/2024
  • 27. 4. Hemostasis and Thrombosis • Normal hemostasis comprises a series of regulated processes that culminate in the formation of a blood clot that limits bleeding from an injured vessel. • The pathologic counterpart of hemostasis is thrombosis, the formation of blood clot (thrombus) within non-traumatized, intact vessels. 4/9/2024 27
  • 30. Con’t.. • The pathologic opposite to hemostasis is thrombosis; • Thrombosis can be considered as an inappropriate activation of normal hemostatic processes, such as the formation of a blood clot (thrombus) in uninjured vasculature or thrombotic occlusion of a vessel after relatively minor injury. • Both hemostasis and thrombosis are regulated by three general components— the vascular wall, platelets, and the coagulation cascade. 4/9/2024 30
  • 31. Thrombosis • Three primary influences predispose to thrombus formation, the so-called Virchow’s triad: (1) Endothelial injury; (2) Stasis or turbulence of blood flow; and (3) Blood hypercoagulability 4/9/2024 31
  • 33. 1. Endothelial Injury • It has the dominant influence; endothelial injury by itself can lead to thrombosis. • It is particularly important for thrombus formation occurring in the heart or in the arterial circulation, • Thus, thrombus formation within the cardiac chambers (e.g., following endocardial injury due to myocardial infarction), or • at sites of traumatic or inflammatory vascular injury (vasculitis) is largely due to endothelial injury. 4/9/2024 33
  • 34. 2.Alterations in Normal Blood Flow/Stasis • Turbulence contributes to arterial and cardiac thrombosis by causing; o endothelial injury or dysfunction o as well as by forming countercurrents and local pockets of stasis; stasis is a major factor in the development of venous thrombi 4/9/2024 34
  • 35. • Normal blood flow is laminar such that the platelets flow centrally in the vessel lumen, separated from the endothelium by a slower-moving clear zone of plasma. • Stasis and turbulence therefore (1) disrupt laminar flow and bring platelets into contact with the endothelium; (2) prevent dilution of activated clotting factors by fresh flowing blood; (3) retard the inflow of clotting factor inhibitors and permit the build-up of thrombi; and (4) promote endothelial cell activation, predisposing to local thrombosis, leukocyte adhesion 4/9/2024 35
  • 36. 3. Hypercoagulability • Hypercoagulability contributes less frequently to thrombotic states. • It is defined as any alteration of the coagulation pathways that predisposes to thrombosis. • The causes of hypercoagulability may be primary (genetic) and secondary (acquired) disorders - Example: pregnancy , HIV/AIDS, Cancer … 4/9/2024 36
  • 37. • Thrombi may develop anywhere in the cardiovascular system: within the cardiac chambers; on valve cusps; or in arteries, veins, or capillaries. • They are of variable size and shape, depending on the site of origin and the circumstances leading to their development. 4/9/2024 37
  • 38. • Arterial or cardiac thrombi usually begin at a site of endothelial injury (e.g., atherosclerotic plaque) or turbulence (vessel bifurcation); • venous thrombi characteristically occur in sites of stasis. • An area of attachment to the underlying vessel or heart wall, frequently firmest at the point of origin, is characteristic of all thromboses. • The propagating tail may not be well attached and, particularly in veins, is prone to fragmentation, creating an embolus. 4/9/2024 38
  • 39. Arterial thrombi : • are usually occlusive; • the most common sites, in descending order, Coronary A, Cerebral A, and  femoral arteries. 4/9/2024 39
  • 40. Fate of the Thrombus • Thrombi undergo some combination of the following four events in days to weeks 1. Propagation. The thrombus may accumulate more platelets and fibrin (propagate), eventually leading to vessel obstruction. 2. Embolization. Thrombi may dislodge and travel to other sites in the vasculature (eg to lung ). 4/9/2024 40
  • 41. 3. Dissolution. Thrombi may be removed by fibrinolytic activity 4. Organization and recanalization. Thrombi may induce inflammation and fibrosis (organization) and may eventually become recanalized; that is, may reestablish vascular flow, or may be incorporated into a thickened vascular wall 4/9/2024 41
  • 42. Outcomes of venous thrombosis 4/9/2024 42

Notes de l'éditeur

  1. Hemodynamics or haemodynamics are the dynamics of blood flow. The circulatory system is controlled by homeostatic mechanisms of autoregulation, just as hydraulic circuits are controlled by control systems. The hemodynamic response continuously monitors and adjusts to conditions in the body and its environment. Hemodynamics explains the physical laws that govern the flow of blood in the blood vessels.
  2. Hyperemia is an active process resulting from arteriolar dilation and increased blood inflow, as occurs at sites of inflammation or in exercising skeletal muscle. Hyperemic tissues are redder than normal because of engorgement with oxygenated blood. Congestion is a passive process resulting from impaired outflow of venous blood from a tissue. It can occur systemically, as in cardiac failure, or locally as a consequence of an isolated venous obstruction.
  3. Major pathogenic pathways in septic shock. Microbial products (PAMPs, or pathogen-associated molecular patterns) activate endothelial cells and cellular and humoral elements of the innate immune system, initiating a cascade of events that lead to end-stage multiorgan failure. Additional details are given in the text. DIC, Disseminated vascular coagulation; HMGB1, high mobility group box 1 protein; NO, nitric oxide; PAF, platelet activating factor; PAI-1, plasminogen activator inhibitor 1; TF, tissue factor; TFPI, tissue factor pathway inhibitor
  4. Normal hemostasis. (A) After vascular injury, local neurohumoral factors induce a transient vasoconstriction. (B) Platelets bind via glycoprotein Ib (GpIb) receptors to von Willebrand factor (VWF) on exposed ECM and are activated, undergoing a shape change and granule release. Released ADP and thromboxane A2 (TXA2) induce additional platelet aggregation through platelet GpIIb-IIIa receptor binding to fibrinogen, and form the primary hemostatic plug
  5. . (C) Local activation of the coagulation cascade (involving tissue factor and platelet phospholipids) results in fibrin polymerization, “cementing” the platelets into a definitive secondary hemostatic plug. (D) Counterregulatory mechanisms, mediated by tissue plasminogen activator (t-PA, a fibrinolytic product) and thrombomodulin, confine the hemostatic process to the site of injury.